MTCH
59
13
EQR
36
5
CTAS
64
2
CSX
37
3
SO
73
3
OI
36
4
MRK
43
2
WMT
66
7
MS
74
4
HSY
34
6
KLAC
72
6
TSN
40
2
PCG
69
2
SEE
60
4
HON
64
5
RHI
29
4
SHW
50
5
PHM
44
3
L
54
3
WDC
63
3
MTCH
59
13
EQR
36
5
CTAS
64
2
CSX
37
3
SO
73
3
OI
36
4
MRK
43
2
WMT
66
7
MS
74
4
HSY
34
6
KLAC
72
6
TSN
40
2
PCG
69
2
SEE
60
4
HON
64
5
RHI
29
4
SHW
50
5
PHM
44
3
L
54
3
WDC
63
3
Financhill
Back

Sonnet BioTherapeutics Holdings Stock Predictions

Is the Traditional House Obsolete?

Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.
Sell
38

SONN
Sonnet BioTherapeutics Holdings

Last Price:
$1.15
Seasonality Move:
-19.03%

7 Day Trial

ALL ACCESS PASS

$ 7

This Company Didn't Survive the AI Reset-It Triggered It. You Can Still Get In Early.

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai. *RAD Intel recently received their ticker reservatio

Sonnet BioTherapeutics Holdings Stock Forecast

  • Is Sonnet BioTherapeutics Holdings Stock Undervalued?
    The current Sonnet BioTherapeutics Holdings [SONN] share price is $1.19. The Score for SONN is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • SONN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Sonnet BioTherapeutics Holdings Stock Go Up Next Year?

Data Unavailable

Sonnet BioTherapeutics Holdings Stock Rating

Data Unavailable

Sonnet BioTherapeutics Holdings Stock Price History

Is SONN stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SONN is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
sonnetbio.com

52-Week Data

52-Week High:
16.00
52-Week Low:
1.08

Prediction Charts

Market Cap:
3.8M
Price in USD:
1.19
Volume:
89.9K
Beta:
0.67

Technical Analysis

SMA50:
1.31
SMA100:
1.44
SMA200:
3.02
52-Wk Change:
-90.98%

Stock Predictions

  • Is Sonnet BioTherapeutics Holdings stock public?
    Yes, Sonnet BioTherapeutics Holdings is a publicly traded company.
  • What is the Sonnet BioTherapeutics Holdings stock quote today?
    The Sonnet BioTherapeutics Holdings stock price is 1.19 USD today.
  • How to buy Sonnet BioTherapeutics Holdings stock online?
    You can buy Sonnet BioTherapeutics Holdings shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-7 1.29 1.29 1.34 1.29
May-8 1.34 1.29 1.34 1.29
May-9 1.29 1.28 1.31 1.28
May-12 1.28 1.33 1.37 1.26
May-13 1.33 1.29 1.35 1.29
May-14 1.29 1.30 1.31 1.29
May-15 1.29 1.23 1.29 1.21
May-16 1.23 1.29 1.30 1.23
May-19 1.29 1.31 1.34 1.29
May-20 1.31 1.30 1.35 1.28
May-21 1.28 1.20 1.31 1.20
May-22 1.21 1.12 1.25 1.08
May-23 1.13 1.13 1.14 1.09
May-27 1.12 1.19 1.21 1.08

Sonnet BioTherapeutics Holdings Earnings

Data Unavailable

Sonnet BioTherapeutics Holdings Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $10.63 per share, a decrease next quarter of $0.00 per share, an increase this year of $9.42 per share, and a decrease next year of $0.00 per share.

* Sonnet BioTherapeutics Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.